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Target of rapamycin (TOR), a master sensor for growth factors and nutrition availability
in eukaryotic species, is a specific target protein of rapamycin. Rapamycin inhibits TOR
kinase activity viaFK506 binding protein 12 kDa (FKBP12) in all examined heterotrophic
eukaryotic organisms. In Arabidopsis, several independent studies have shown that
AtFKBP12 is non-functional under aerobic condition, but one study suggests that
AtFKBP12 is functional during anaerobic growth. However, the functions of AtFKBP12
have never been examined in parallel under aerobic and anaerobic growth conditions
so far. To this end, we cloned the FKBP12 gene of humans, yeast, and Arabidopsis,
respectively. Transgenic plants were generated, and pharmacological examinations
were performed in parallel with Arabidopsis under aerobic and anaerobic conditions.
ScFKBP12 conferred plants with the strongest sensitivity to rapamycin, followed by
HsFKBP12, whereas AtFKBP12 failed to generate rapamycin sensitivity under aerobic
condition. Upon submergence, yeast and human FKBP12 can significantly block
cotyledon greening while Arabidopsis FKBP12 only retards plant growth in the presence
of rapamycin, suggesting that hypoxia stress could partially restore the functions of
AtFKBP12 to bridge the interaction between rapamycin and TOR. To further determine
if communication between TOR and auxin signaling exists in plants, yeast FKBP12 was
introduced into DR5::GUS homozygous plants. The transgenic plants DR5/BP12 were
then treated with rapamycin or KU63794 (a new inhibitor of TOR). GUS staining showed
that the auxin content of root tips decreased compared to the control. DR5/BP12 plants
lost sensitivity to auxin after treatment with rapamycin. Auxin-defective phenotypes,
including short primary roots, fewer lateral roots, and loss of gravitropism, occurred
in DR5/BP12 plants when seedlings were treated with rapamycin+KU63794. This
indicated that the combination of rapamycin and KU63794 can significantly inhibit TOR
and auxin signaling in DR5/BP12 plants. These studies demonstrate that TOR is essential
for auxin signaling transduction in Arabidopsis.
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INTRODUCTION
Rapamycin (also known as sirolimus), a macrolide antibiotic,
is produced by the soil bacterium, Streptomyces hydroscopicus.
All tested heterotrophic eukaryotes, including yeast, nematodes
(Caenorhabditiselegans), fruit flies (Drosophila), and mammals,
are sensitive to rapamycin (Xiong and Sheen, 2015). Rapamycin
feeding mimics nutrition restriction and energy depletion and
thus significantly extends the lifespans of mammals and plants
(Fontana et al., 2010; Ren et al., 2012). Rapamycin is therefore
a research focus of human preventive medicine. Interestingly,
most plants are insensitive to rapamycin under aerobic growth
condition (Xu et al., 1998; Menand et al., 2002; Ren et al., 2012;
Montané and Menand, 2013). This insensitivity might involve
self-immune mechanisms. From an evolutionary perspective,
billions of years separate the beginnings of yeast and the
development of human cells, yet human cell exposure to
rapamycin produces the same nutrition starvation phenomenon
as found in yeast. This indicates a highly conserved target for
rapamycin in eukaryotes. TOR1 and TOR2 genes, targets of
rapamycin, have been identified in budding yeast and this has
allowed advanced TOR studies (Cafferkey et al., 1993; Kunz
et al., 1993; Sabatini et al., 1994; Chen et al., 1995; Loewith
et al., 2002). Since its initial discovery, the TOR gene has
been isolated from all examined eukaryotic organisms. Most
eukaryotic organisms contain only one TOR gene, whereas two
and three TOR genes exist in yeast and Leishmania major,
respectively (Madeira Da Silva and Beverley, 2010). Disruption
of the TOR gene is lethal in eukaryotes, indicating that TOR is
required for life in eukaryotic cells (Wullschleger et al., 2006).
Disruption of the TOR signal is one of the major causes of
nutrition-related diseases in animals and humans, including
diabetes, cancer, and cardiovascular disease (Zagouri et al., 2012;
Cornu et al., 2013). TOR function is highly conserved from
yeast to humans, and it controls key biological processes such
as ribosome biogenesis, protein synthesis, three carboxylic acid
cycles, and stress responses (Fontana et al., 2010; Cornu et al.,
2013).
The 12-KDa FK506-binding protein 12 (FKBP12) is the
receptor protein of rapamycin and it mediates the interaction
between TOR and rapamycin (Brown et al., 1994). In yeast
and mammals, rapamycin first forms a heterogeneous complex
with FKBP12 and then specifically targets and binds to the
FRB domain of TOR to form a rapamycin-FKBP12-TOR
complex that in turn inhibits the kinase activity of TOR (Chiu
et al., 1994; Sabatini et al., 1994; Choi et al., 1996). In this
rapamycin-FKBP12-TOR system, FKBP12 plays a crucial role by
being directly involved in rapamycin recognition and binding.
Mutations in the FKBP12 gene result in rapamycin insensitivity
in yeast (Koltin et al., 1991). TOR deletion is lethal, and all
tested fungi and animals are sensitive to rapamycin (Heitman
et al., 1991; Loewith et al., 2002; Wullschleger et al., 2006).
Based on the rapamycin-FKBP12 negative regulation system
of TOR, TOR and its signaling pathway in yeast and animals
have been extensively studied. The structure and function of
FKBP12 proteins are highly conserved and human FKBP12
can functionally complement that of yeast (Koltin et al., 1991).
Although the amino acid sequences of plant FKBP12s are
relatively similar to those of yeast and mammals, wild-type (WT)
Arabidopsis is insensitive to rapamycin and does not express any
detectable phenotypes even at high concentrations (20µg/mL
rapamycin) under aerobic condition (Xu et al., 1998; Menand
et al., 2002; Mahfouz et al., 2006; Sormani et al., 2007; Ren et al.,
2012;Montané andMenand, 2013). Various genetic, biochemical,
yeast two hybrid (Y2H), and pharmacological analyses have
demonstrated that plant FKBP12 does not have the ability to form
rapamycin/FKBP12/TOR complexes (Xu et al., 1998; Sormani
et al., 2007; Moreau et al., 2012; Ren et al., 2012; Montané
and Menand, 2013). However, overexpression of AtFKBP12 can
dramatically enhance rapamycin sensitivity during anaerobic
growth (Xiong and Sheen, 2012). This observation invalidates
the common belief that TOR signaling in Arabidopsis is always
insensitive to rapamycin, but the AtFKBP12 transgenic plants
have never been carefully examined in parallel under aerobic and
anaerobic growth condition so far.
Growth factors such as insulin and IGF in mammals are the
key signals determining cell growth, proliferation, differentiation,
and fate. TOR has a close relationship with growth factors
(Wang et al., 2006; Vander Haar et al., 2007; Feng and
Levine, 2010). In plants, auxin is the major phytohormone and
growth factor controlling the cell cycle, division, elongation,
differentiation, growth, and development (Teale et al., 2006).
Auxin and growth factors can activate the TOR signaling
pathway to modulate specific mRNA transcription, translation,
translation re-initiation, and selective protein synthesis by
phosphorylating key downstream regulators such as S6 ribosomal
protein kinase (S6K), S6 ribosomal protein, and eukaryotic
initiation factor 4E (eIF4E; Dinkova et al., 2000; Beltrán-Peña
et al., 2002; Bögre et al., 2013; Schepetilnikov et al., 2013;
Villa-Hernández et al., 2013). Our recent observations indicate
that many auxin signaling associated genes are differentially
expressed in Arabidopsis seedlings treated with AZD8055 (one
of asTORis; Dong et al., 2015). TOR therefore appears to
play a crucial role in mediating auxin signals. However, one
study reported that auxin is decoupled from TOR activation in
Arabidopsis (Xiong et al., 2013). To clarify the issues concerning
FKBP12 functions and the relationship between auxin and
TOR signaling in plants, we cloned FKBP12 from human
(HsFKBP12), yeast (ScFKBP12) and Arabidopsis (AtFKBP12) and
generated overexpression transgenic lines of Arabidopsis. The
functions of HsFKBP12, ScFKBP12 and AtFKBP12 were tested
in parallel for their sensitivity to rapamycin under aerobic and
anaerobic conditions. Our results demonstrate that plants can
acquire rapamycin sensitivity by overexpression of HsFKBP12
or ScFKBP12, and ScFKBP12 showed more pronounced
effects than HsFKBP12 under both aerobic and anaerobic
growth conditions. No rapamycin response was observed from
transgenic plants containing P35S::AtFKBP12 during aerobic
growth, but the rapamycin sensitivity can be partially rescued in
response to submergence. Double transgenic plants named after
DR5/BP12s, which contained P35S::ScFKBP12 and DR5:: GUS,
were generated. When DR5/BP12 plants were simultaneously
treated with rapamycin and KU63794 (KU), normal growth and
development of the roots was inhibited and the root geotropism
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was also altered. This was a classic phenotype of defective
auxin signaling. GUS staining showed that auxin distribution
was reduced in DR5/BP12 plants in the presence of the TOR
inhibitor. TOR significantly influenced the concentration and
response of auxin in the plant and altered the downstream signal
response processes.
MATERIALS AND METHODS
Plant Materials and Growth Conditions
In the present study, wild-type (WT) Arabidopsis Columbia
(Columbia-0) ecotype and transgenic lines were grown in
growth chambers with 16 h light/8 h dark photoperiod at 22◦C.
Transgenic plants were generated using the floral dipping
method (Zhang et al., 2006). In all cases, A. thaliana seeds were
surface-sterilized for 5min in 70% ethanol, and then washed in
10% sodium hypochlorite containing 0.3% Tween-20. Finally,
seeds were washed five times with sterilized water. Before sowing
on plates, the seeds were incubated for 2 days at 4◦C in the dark.
RNA Extraction and Generation of
Overexpression Constructs
Total RNAwas extracted fromArabidopsisColumbia (Columbia-
0) and human cells using TRIzol (Invitrogen), following the
manufacturer’s protocol. cDNA was synthesized by using the
TransScript One-Step gDNA Removal and cDNA Synthesis
SuperMix kit (Transgen). The full-length coding sequence
of HsFKBP12 and AtFKBP12 was amplified by TransStarTaq
DNA Polymerase (Transgen) using the corresponding primers
(Supplementary Table 1). PCR primers for amplification of the
full-length genes from Arabidopsis were designed based on its
cDNA sequence (http://www.Arabidopsis.org, http://www.ncbi.
nlm.nih.gov). A NotI site at the 5′ end of the forward primer
and a Sbf I site at the 3′ end of reverse primer were introduced.
The remaining steps of plasmid construction were performed as
described elsewhere (Ren et al., 2012).
Quantitative Real-Time PCR and Semi-RT
PCR
Samples were collected and frozen in liquid nitrogen for total
RNA extraction using the RNAprep Pure Plant Kit (TianGen
Biotech). Approximately 1µg of total RNA was then used
for reverse transcription. qRT-PCR was performed using the
TransStart Top Green qPCRSuperMix (TransgenBiotech) kit,
following the manufacturer’s protocol and using a two-step
method for PCR reaction. The PCR parameters included 94◦C
pre-denaturation for 30 s, followed by 40 cycles of the following
two steps: 5 s at 94◦C and 30 s at 60◦C. Plant actin2 was used as
constitutive reference. The primers used in the present study were
listed in Supplementary Table 1.
EasyTaq DNA Polymerase (TransGen Biotech) was used for
semi-RT PCR, following the manufacturer’s protocol. The PCR
parameters included 94◦C pre-denaturation for 5min, followed
by 24 cycles for the following three steps: 30 s at 94◦C, 30 s at
55◦C, and 30 s at 72◦C. This was then followed by incubation for
10min at 72◦C for final extension.
Generation of Promoter-GUS Constructs
The genomic DNA ofArabidopsiswas extracted fromArabidopsis
Columbia (Columbia-0) using one step Plant DNA Extraction
Reagent (BIOTEKE), following the manufacturer’s protocol.
Based on our previous PRPS6B:: GUS construct (Ren et al.,
2012), the PRPS6B was replaced by the promoter of AtFKBP12
(1.1 kb) at the AsisI and NotI restriction sites, respectively. Then
PAtFKBP12:: GUS construct was transferred into the destination
vector, pEarleyGate303, via LR recombination reactions. The
primers of PAtFKBP12 are listed in the Supplementary Table 1.
Western Blotting
Total protein was extracted using a cell lysis buffer for Western
and IP (Biyuntian), which contained 20mMTris (pH7.5),
150mMNaCl, 1%Triton X-100, sodium pyrophosphate,
β-glycerophosphate, EDTA, Na3VO4, and leupeptin.
Approximately 1mM of phenylmethylsulphonyl fluoride
(PMSF), 1 × Protease Inhibitor Cocktail (Sigma), and 1 ×
Phosphatase Inhibitor Cocktail 3 (Sigma) were added to the
cell lysis buffer for Western and IP prior to the extraction
process. The supernatant was collected after centrifugation
at 12,000 rpm and quantified by using the RC/DC protein
assay kit (BioRad). Approximately 40µg of total protein was
loaded onto a 15% SDS-PAGE gel. After electrophoresis and
electroblotting, PVDF membranes (GE) were blocked with milk
blocking buffer (Cwbio) for 12 h (overnight) at 4◦C and then
incubated in blocking buffer containing anti-HA or anti-Myc
(dilution: 1:1000; Earthox, E022010-01, E022050-01) for 2 h at
room temperature. The PVDF membrane was washed three
times (10min each) with PBST (Cwbio). The secondary antibody
[HRP, goat anti-mouse IgG (H+L) Earthox, E030110-01] was
diluted 1:10,000 with PBST. Incubation and elution of the
secondary antibody were performed as previously described.
Proteins were detected using the cECLWestern Blot Kit (Cwbio).
Rapamycin Sensitivity Test
Our previous study have shown that low concentrations of
rapamycin severely inhibit the growth of BP12-2 (Ren et al.,
2012). In current work, a rapamycin concentration gradient from
0 to 5µM was added to 0.5MS medium, and DMSO was used
as control. Four kinds of plant seeds, including the WT, BP12-
2, P35S:: AtFKBP12, and P35S:: HsFKBP12were surface-sterilized
and sowed on the medium. After 10 days, differences between
various treatments and materials were assessed, and fresh weight
and root length were measured. Under liquid growth condition,
3ml 0.5MS liquid medium with DMSO or rapamycin was added
into 6-well plate. The liquid medium was refreshed every 2 days.
Fresh Weight and Root Growth
Measurements
Plants were grown on 0.5MS medium with different TOR
inhibitors. After 10 days growth, all Petri dishes were
photographed, and the fresh weight of plants was determined by
weighing. Root length measurements were repeated four times
per treatment by using the ImageJ software, and measurements
for fresh weight and lateral root density were repeated four
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times. The measurement for lateral root initiation index was as
described elsewhere (Dubrovsky et al., 2009).
β-GUS Staining
GUS staining was performed as previously described (Menand
et al., 2002) at 6 h for PAtFKBP12:: GUS, 30min for 35S:: GUS,
and 1 h for DR5/BP12-OE11.
RESULTS
Overexpression of ScFKBP12 and
HsFKBP12, but Not AtFKBP12, Rescues
Arabidopsis Rapamycin Sensitivity under
Aerobic Growth Condition
Most plants are resistant to rapamycin in solid medium (Xu et al.,
1998;Menand et al., 2002; Ren et al., 2012;Montané andMenand,
2013). Two hypotheses are proposed for rapamycin insensitivity
in plants. One hypothesis is that rapamycin resistance in
plants is due to the low expression of FKBP12. Another
hypothesis is the currently accepted opinion that plant FKBP12s
cannot bind to rapamycin. To study the first hypothesis, the
AtFKBP12 promoter was amplified from Arabidopsis genomic
DNA, and the PAtFKBP12::GUS plasmid was constructed and
transformed into WT Arabidopsis. A total of 12 independent
transgenic plants containing PAtFKBP12:: GUS were obtained
and confirmed by DNA-PCR using GUS specific primers
(Supplementary Table 1). GUS staining showed that the GUS
signal of PAtFKBP12:: GUS plants was much lower than
that of P35S:: GUS transgenic plants, which were generated
in a previous study (Figure 1A; Ren et al., 2011). Total
RNA from different tissues of Arabidopsis, including roots,
stems, leaves, flowers, and siliques was extracted to determine
tissue-specific expression of the AtFKBP12 gene. qRT-PCR
analysis showed that AtFKBP12was constitutively expressed in
Arabidopsis (Figure 1B). The expression level of AtFKBP12
FIGURE 1 | The expression pattern of AtFKBP12 in Arabidopsis and the identification of transgenic lines of AtFKBP12, HsFKBP12 and
PAtFKBP12::GUS in Arabidopsis. (A) The GUS staining of PAtFKBP12::GUS and P35S::GUS transgenic lines. 5 DAG (days after germination) seedlings were
stained. (a,b) bar = 0.5 cm; (c–f) bar = 2mm; (g) bar = 0.2mm. (B) qRT-PCR to detect expression pattern of AtFKBP12 in different Arabidopsis tissues. (C)
qRT-PCR to detect expression level of AtFKBP12 or HsFKBP12 in transgenic lines. Asterisks denote Student’s t-test significance compared with WT
(*P < 0.05; **P < 0.01). (D) The protein expression level in three FKBP12 transgenic lines. AtFKBP12 and HsFKBP12 used anti-HA antibody; BP12-2 used anti-MYC
antibody. (E) The multiple protein sequence alignment of ScFKBP12, HsFKBP12, and AtFKBP12. Significant mutations were marked with red box.
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was higher in the leaves and flowers than in the roots, stems, and
siliques.
To further examine whether rapamycin insensitivity in
Arabidopsis in solid medium results from the low expression
of AtFKBP12, transgenic lines containing P35S::AtFKBP12 were
prepared. A total of 25 independent lines were identified
by PCR analysis of leaf tissue. A total of 14 independent
lines (OE1–14) were selected for expression profiling of
AtFKBP12 by semi-qPCR. The AtFKBP12transcript was detected
in all 14 independent lines, whereas the expression levels of
AtFKBP12varied among the different lines. Four lines with the
highest AtFKBP12 expression levels were selected for qRT-PCR
analysis (Figure 1C). For the rapamycin sensitivity assay, all
transgenic lines were grown on solid medium supplemented
with 5µM rapamycin, and the results demonstrated that all
lines, including the highest overexpression lines (OE1, OE3,
OE5, and OE14) and the lowest overexpression lines (OE2 and
OE6) were insensitive to rapamycin under aerobic condition
(Table 1). These findings indicate that the expression level of
AtFKBP12 was not related to rapamycin insensitivity in plants.
This observation was consistent with most previous studies (Xu
et al., 1998; Menand et al., 2002; Mahfouz et al., 2006; Sormani
et al., 2007; Ren et al., 2012; Montané and Menand, 2013).
To verify this result, we cloned HsFKBP12 from human
cells and generated 25 independent P35S::HsFKBP12 transgenic
lines. OE1–OE14 were selected for semi-qPCR and qRT-PCR
analyses and treated with 5µM rapamycin similar to that
of AtFKBP12 lines (Table 1, Figure 1C). In contrast to the
P35S::AtFKBP12 lines, all 14 P35S::HsFKBP12 lines (OE1-OE14)
responded to rapamycin (Table 1). In previous studies, we have
extensively characterized the rapamycin sensitivity of BP12-2,
which has a single copy of P35S::ScFKBP12 and is hypersensitive
to rapamycin (Ren et al., 2012). In the present study, AtFKBP12-
OE3, AtFKBP12-OE5, HsFKBP12-OE1, HsFKBP12-OE3 showed
higher expression levels among all tested transgenic lines of
AtFKBP12 and HsFKBP12, respectively. Western blot results
confirmed that the expression of AtFKBP12 and HsFKBP12
proteins were similar and significantly higher (Figure 1D
and Supplementary Figure 1A). We therefore selected them
for subsequent rapamycin sensitivity testing using procedures
described earlier. Figure 2 shows that all tested lines had
normally growth on 1/2MS solidmediumwith DMSO, indicating
that overexpression of AtFKBP12, ScFKBP12, and HsFKBP12
had no obvious effect on plant growth. However, in the presence
of rapamycin, BP12-2 plants showed hypersensitivity, followed
by HsFKBP12-OE1 and OE3, whereas the AtFKBP12 transgenic
TABLE 1 | Screening and identification of transgenic material.
Transgenic lines Leaf PCR
test positive
Rapamycin
sensitivity test
Rapamycin sensitivity
test positive
PAtFKBP12::GUS 20 – –
AtFKBP12-OE 25 14 0
HsFKBP12-OE 27 14 14
DR5/BP12-OE 20 6 6
OE means overexpression.
lines and WT plants did not respond to rapamycin treatment
(Figure 2A). The administration of a low concentration of
rapamycin (0.1µM) resulted in a delay in the growth and
development of BP12-2, and its fresh weight decreased by nearly
50% compared to theWT (Figure 2E). Administration of 0.1µM
rapamycin did not result in strong detectable inhibitory effects on
HsFKBP12-OE1 and OE3. However, with increased rapamycin
concentration, the HsFKBP12 transgenic lines also exhibited
strong inhibitory effects (Figure 2A). When the concentration of
rapamycin reached to 5µM, its inhibitory effect on HsFKBP12-
OEs was pronounced (Figures 2A–C). Root and root hair
length significantly decreased, leaf size was reduced, and plant
fresh weight decreased by >50% (Figures 2D,E). At high
concentration of rapamycin, the growth suppression of BP12-2
was still stronger than in HsFKBP12-OE lines. In contrast, the
P35S::AtFKBP12 transgenic lines did not show clear inhibitory
effects and had phenotypes similar to those of the WT control
(Figure 2).
Submergence Can Partially Restore
Rapamycin Sensitivity of AtFKBP12 in
Arabidopsis
Unlike above observations, previous study showed that
AtFKBP12 is able to bridge the interaction between rapamycin
and TOR in liquid culture (Xiong and Sheen, 2012). To further
examine this observation and the functions of ScFKBP12,
HsFKBP12 and AtFKBP12 in parallel under anaerobic growth
condition, the sterile seeds of WT, BP12-2, HsFKBP12-OE1
and AtFKBP12-OE5 have been germinated in 0.5xMS liquid
medium containing 10µM rapamycin and grown for 8 days,
respectively. The Supplementary Figure 2 showed that the
seedling growth of BP12-2, HsFKBP12-OE1, and AtFKBP12-
OE5 were indistinguishable from WT plants in terms of its
response to submergence in 0.5xMS liquid medium with DMSO.
However, the cotyledon greening, primary root elongation
and fresh weight of BP12-2, followed byHsFKBP12-OE1,have
been significantly arrested in the presence of rapamycin
(Supplementary Figure 2). These results indicate that the
combination of rapamycin and hypoxia could generate additive
inhibition effects on TOR activity which are in agreement with
recent observations in mammals (Bedogni et al., 2005; Agarwal
et al., 2016; Damerill et al., 2016). Importantly, submergence
can partially inhibit seedling growth of AtFKBP12-OE5 when
compared with WT in the presence of 10µM rapamycin
(Supplementary Figure 2). This observation likely suggests that
anaerobic stress caused by submergence can partially rescue the
functions of AtFKBP12 to interact with TOR and rapamycin.
Generation of Double Transgenic
DR5/BP12 Plants Containing Both
P35S::ScFKBP12 and DR5:: GUS
Differing observations on the relationship between TOR and
auxin signaling were reported by different groups (Dinkova et al.,
2000; Beltrán-Peña et al., 2002; Schepetilnikov et al., 2013; Xiong
et al., 2013; Dong et al., 2015). The above results indicated that
under aerobic and anaerobic growth conditions, the rapamycin
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FIGURE 2 | Rapamycin sensitivity tests of the transgenic plants with ScFKBP12, HsFKBP12, and AtFKBP12 . (A) Dose-dependent effect of rapamycin on
the growth and development of WT and three transgenic plants. The concentration of rapamycin ranged from 0 to 5µM (10 DAG). Bar = 1 cm. (B,C) The root hair
and leaf growth of WT and three transgenic plants on 0.5 MS medium supplied with DMSO or rapamycin (5µM). (B) Bar = 1mm; (C) Bar = 0.5 cm. (D,E) Quantitative
analysis and comparison of the root length and the fresh weight (%) of WT and three transgenic plants after treatment with rapamycin. Error bars indicate ±SD for
quadruplication.
sensitivity of Arabidopsiscanbe rescued by ScFKBP12 in the
most significant manner. ScFKBP12 was therefore selected
for subsequent analysis of TOR signaling in Arabidopsis. To
further investigate the relationship between TOR and auxin,
we introduced the P35S:: ScFKBP12 construct (with a BASTA
selection marker) into DR5:: GUS homozygous Arabidopsis
lines, which have been used as an auxin signal reporter (Xiang
et al., 2011). A total of 20 independent double transgenic lines
containing both DR5:: GUS and P35S:: ScFKBP12 were generated
by screening T0 transgenic seeds sown on 0.5MS medium
plate containing BASTA (10mg/L). DNA-PCR analysis indicated
that these lines contained both DR5::GUS and P35S::ScFKBP12
constructs. We named these double transgenic plants as
DR5/BP12-OE lines (Table 1). The T2 generation seeds of these
20 DR5/BP12-OE lines were collected for the BASTA segregation
assay. The results showed that 6 of 20 lines displayed a 3:1
Mendelian segregation ratio for BASTA resistance and sensitivity,
indicating that these 6 lines likely contained a single copy of
P35S:: ScFKBP12. T3 generation seeds of these 6 lines were
then selected for rapamycin sensitivity testing, which showed
that all 6 lines were similarly sensitive to rapamycin treatment
(Table 1). Semi-qPCR and qRT-PCR analyses indicated that
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DR5/BP12-OE5 and DR5/BP12-OE11 exhibited higher levels of
ScFKBP12 expression than the other lines (Figures 3F,G). They
were therefore selected for subsequent experiments.
The Combination of Low-Concentration
Rapamycin and KU Significantly Inhibits
Seedling Growth and Development
When DR5/BP12-OE5 and DR5/BP12-OE11 were treated with
concentrations of rapamycin ranging from 5 to 20µM, the plants
showed no obvious growth differences related to increasing of
rapamycin concentration. So 5µM seemed to be the saturation
concentration of rapamycin (Supplementary Figure 3). This
result indicated that rapamycin alone did not inhibit TOR
function, even at higher concentrations. To proceed further,
studies using second-generation TOR inhibitors to rapamycin-
BP12-2 systems should be conducted. AsTORis have been
developed and extensively utilized as second-generation TOR
inhibitors both in basic scientific research studies and clinical
trials (Benjamin et al., 2011). AsTORis directly interact
with the kinase domain of TOR by competing with ATP,
thereby inhibiting the kinase activity of TOR. More than 30
FIGURE 3 | KU sensitivity tests of WT, DR5::GUS and DR5/BP12-OE transgenic lines and the identification of transgenic lines of DR5/BP12-OE
transgenic lines. (A) The leaf formation of DR5::GUS and DR5/BP12-OE11 after treatment with different concentration of KU (10 DAG). Bar = 0.5 cm. (B)
Dose-dependent inhibitory effect of KU on WT, DR5:: GUS and DR5/BP12-OE plants growth. The KU concentration ranged from 0 to 20µM (10 DAG). Bar=1 cm.
(C–E) The quantitative analysis and comparison of fresh weight (%), root length (%) and lateral root initiation index (%) (LR initiation index) of DR5::GUS and
DR5/BP12-OE plants after treating with KU at different concentration. Error bars indicate ±SD for quadruplication. (F,G) Identification of transgenic lines of
DR5/BP12-OE lines by semi-qPCR, western blot (F, note: Since some results of the western blot located between DR:GUS and T3-5 are not associated with this
manuscript, part of the membrane has been cut out), and qRT-PCR (G).
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asTORis have been developed to date. Different asTORis have
different structures and different IC50 (half maximal inhibitory
concentration). KU63794 (KU), Torin1 and AZD8055 represent
mild, moderate and strong inhibitors of TOR, respectively. They
have frequently been used in TOR studies onmammalian systems
and in plants (Montané and Menand, 2013; Schepetilnikov et al.,
2013; Xiong et al., 2013; Dong et al., 2015; Li et al., 2015).
However, Torin1 and AZD8055 show some off-target effects on
PI3Ks (Thoreen et al., 2009; Chresta et al., 2010; Liu et al., 2010).
In contrast, KU displayed the highest specificity toward TOR
with no detectable off-target effects (García-Martínez et al., 2009).
KU was therefore selected as an ATP competitive inhibitor of
TOR for this study.
The inhibitory effect of KU was initially tested using
concentration-gradient treatments (Figure 3). KU inhibited
plant growth in a dose-dependent manner. When the KU
concentration was <2µM, root length of DR5/BP12-OE5
and DR5/BP12-OE11 was reduced compared to the DMSO
control but no obvious differences in leaf development were
observed. With higher (10–20µM) KU concentrations, strong
inhibitory effects were observed. Root development inDR5::GUS,
DR5/BP12-OE5, and DR5/BP12-OE11 was inhibited. Leaf
formation was impaired, and the true leaves were smaller
and chlorotic (Figures 3A,B). The fresh weight of the whole
plant decreased significantly. The 20µM KU concentration
completely inhibited plant growth. Phenotype and related data
analysis (Figures 3A–E) indicated that the concentration range of
3–5µMwas critical to plant growth, and possibly the IC50 of KU.
We then tested various combinations of rapamycin
and KU. Rapamycin combined with KU in the medium
produced inhibition in the development of DR5/BP12-
OE5 and DR5/BP12-OE11 in a dose-dependent manner
(Supplementary Figure 4). When the concentration of KU
remained at 1µM, the WT lines showed no inhibitory
effect at any rapamycin concentration, whereas DR5/BP12-
OE5 and DR5/BP12-OE11showed severe inhibitory
effects on root length (Supplementary Figures 4A,D), leaf
development (Supplementary Figure 4B), and fresh weight
(Supplementary Figure 4D). In contrast, the combination of
5µM KU with gradually increased rapamycin concentrations
resulted in a more pronounced inhibitory effect that was
phenotypically expressed in the DR5/BP12-OEtreated lines
FIGURE 4 | The inhibition of Arabidopsis by combined rapamycin with KU. (A) The growth of whole plant of DR5:: GUS and DR5/BP12-OE11 after treated
with rapamycin and KU (10 DAG). Rapamycin concentration ranged from 0 to 5µM, whereas KU was used at a final concentration of 5µM. Bar = 1 cm. (B) The
inhibitory effect of KU or rapamycin plus KU on root hair development and leaf formation of DR5:: GUS and DR5/BP12-OE11. Bar = 1mm at the left and 0.5 cm in the
right. (C,D) The quantitative analysis and comparison of root length (%) and fresh weight (%) of WT, DR5::GUS and DR5/BP12-OE plants after treatment with
rapamycin or/and KU. Error bars indicate ±SD for quadruplication.
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(Figure 4A). Comparison of the combination of 1µM KU plus
rapamycin with 5µM KU plus rapamycin showed that the latter
combination had greater growth inhibition (Figure 4). With
0.5µM rapamycin and 5µM KU, growth and development of
DR5/BP12-OE5andDR5/BP12-OE11was completely terminated,
and nearly no root growth or true leaf formation were observed.
TOR Inhibitors Affect Arabidopsis Auxin
Signals
Auxin related plant effects could be distinguished from
DR5/BP12-OE11 treated with rapamycin plus KU
(Figures 5A,B). Severe growth and development defects, as
well as geotropism in DR5/BP12-OE5 and DR5/BP12-OE11
were seen when the combined concentration of rapamycin
and KU reached 5µM. These findings suggested that severe
inhibition of TOR would also affect the auxin signal pathway
of plants. To investigate inhibitory effects of TOR on auxin,
we examined the GUS signals of DR5/BP12-OE11 treated with
rapamycin or/and KU (5µM), with DMSO used as control
(Figure 5C). The content of auxin in the root tips of inhibitor-
treated lines significantly decreased compared to the control,
indicating that the auxin levels were affected by TOR inhibitors.
Next, four auxin biosynthesis-related genes, ATT1, TAR2,
YUCCA1, and YUCCA2, were selected for mRNA expression
analysis following TOR inhibitor treatment. ATT1 and TAR2
are genes involved with the first step of auxin biosynthesis.
FIGURE 5 | The inhibition of DR5:: GUS and DR5/BP12-OE11 by rapamycin or/and KU affect auxin levels. (A) The phenotype of DR5::GUS and
DR5/BP12-OE11 treated with rapamycin or/and KU. DMSO was used as control (12 DAG). Bar = 1 cm. (B) The changed gravitropism of plant root. Plants grew for
12 din 0.5MS medium with different TOR inhibitors or DMSO. Bar = 1 cm. (C) Rapamycin or/and KU affect auxin distribution in root tip, DR5:: GUS reporter was used
as a marker of auxin distribution. Plants grew for 7 d in 0.5MS medium with different TOR inhibitors or DMSO. Bar = 0.1mm. (D) Detection expression level of auxin
synthesis-related genes by qRT-PCR. DR5/BP12-OE11 grew 12 days in 0.5MS medium with different TOR inhibitors [RAP (5µM), KU (5µM), RAP (5µM) +KU
(5µM); DMSO was used as control]. Each value represents the mean± SD of 3 independent experiments. Asterisks denote Student’s t-test significance compared
with control (*P < 0.05; **P < 0.01).
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They catalyze the formation of indole-3-pyruvic acid (IPA)
from tryptophan. YUCCA1 and YUCCA2 catalyze the formation
of IAA from IPA (Mashiguchi et al., 2011). Compared to the
DMSO control lines, ATT1, TAR2, YUCCA1, and YUCCA2
were all significantly down regulated in TOR inhibitor-treated
lines (Figure 5D and Supplementary Figure 4E). The TOR
inhibitors therefore reduced the auxin levels in Arabidopsis. The
observed down-regulation of auxin levels was also consistent
with the disruption in root development in TOR inhibitor-
treated DR5/BP12-OE5 and DR5/BP12-OE11. We added
exogenous auxin to assess the response of rapamycin-treated
DR5/BP12-OE5 and DR5/BP12-OE11. Figure 6 shows that the
low concentration of exogenous auxin effectively promoted
lateral root and root hair development in the absence of a
TOR inhibitor. Under rapamycin treatment, no changes were
observed in DR5:: GUS, whereas the DR5/BP12-OE5 and
DR5/BP12-OE11 lines showed severe impairment of lateral
root formation and root hair elongation (Figures 6B–D). The
addition of different doses of exogenous auxin resulted in partial
restoration of root hair development in low-concentration
inhibitor-treated plants (Figures 6B,D). With 5µM of
rapamycin, lateral root development in the DR5/BP12-OE5
FIGURE 6 | TOR was required for exogenous IAA response in Arabidopsis. (A) The phenotype of DR5/BP12-OE11 treated with IAA and rapamycin (8 DAG).
Bar = 1 cm. (B) The root hair elongation of DR5:: GUS and DR5/BP12-OE11 with exogenous IAA and rapamycin. Bar = 1mm. Error bars indicate ±SD for
quadruplication. (C,D) The quantitative analysis and comparison of LR initiation index (%) and root hair length (%) of WT, DR5::GUS and DR5/BP12-OE plants after
treatment with IAA and rapamycin. Error bars indicate ±SD for quadruplication. Asterisks denote Student’s t-test significance compared with DR5:: GUS (**P < 0.01).
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and DR5/BP12-OE11 lines was completely inhibited regardless
of supplementation with higher amounts of exogenous auxin.
These results indicate that TOR is involved in the auxin
response.
The regulatory functions of auxin in plants include apical
dominance, tropism, root germination, stem extension, organ
differentiation, and aging (Teale et al., 2006; Zhao, 2010).
In the presence of auxin, AUX/IAA repressor proteins are
rapidly degraded by the ubiquitination pathway and then the
transcription of primary auxin response genes (SAUR, GH3, and
AUX/IAA family) are activated within a few minutes (Dharmasiri
and Estelle, 2004; Wang and Estelle, 2014). In the present
study, we utilized auxin response genes as qRT-PCR markers
for auxin responses in DR5/BP12-OE11, which was exposed to
TOR inhibitors. Based on previous results of expression profiling
analysis (Dong et al., 2015), six genes were selected for gene
expression analysis at the mRNA level. Figure 7 shows that all
auxin response genes were down-regulated by rapamycin or
KU treatment. This differential expression was most obvious
when the DR5/BP12-OE11 line was treated with rapamycin
plus KU. To further study the effects of TOR inhibitors on
auxin signaling, two auxin biosynthesis-related genes and two
primary auxin response genes were chosen as markers to study
the impact of TOR inhibitors on auxin signals at different time
points (Supplementary Figure 5). The results show that the four
selected genes were down-regulated at 10min after treatment.
This result indicates that TOR inhibitors could rapidly affect the
expression of primary auxin response genes by down-regulation
the expression of auxin biosynthesis-related and responsive genes
to block auxin signaling. However, YUCCA genes and SAURs
were up-regulated with longer treatment times. This result may
be due to the feedback regulation of YUCCA genes in the lack
of auxin (Suzuki et al., 2015). The up-regulation of YUCCA
genes might indicate that auxin levels were down-regulated by
TOR inhibitors in Arabidopsis. In contrast to rapamycin or KU
alone, rapamycin plus KU could quickly inhibit auxin signaling
and disrupt that feedback system. This might explain why
rapamycin plus KU strongly inhibit the growth and development
of Arabidopsis. The treatment with TOR inhibitors caused a
significant change in the transcriptional expression levels of
these genes. Therefore, TOR is crucial in auxin homeostasis and
significantly affected the auxin signal pathway in plants.
FIGURE 7 | The expression level of primaryauxin response gene family AUX/IAAs, SAURs, and GH3s were affected by TOR specific inhibitors.
DR5/BP12-OE11 grew in 0.5MS medium containing TOR inhibitors [RAP (5µM), KU (5µM), RAP (5µM ) + KU (5µM); DMSO was used as control)] for 12 days. Each
value represents the mean± SD of 3 independent experiments. Asterisks denote Student’s t-test significance compared with control (*P < 0.05; **P < 0.01).
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DISCUSSION
Hypoxia Stress Could Enhance the
Interactions between TOR, FKBP12 and
Rapamycin in Arabidopsis
Several independent studies have shown that plant FKBP12
is non-functional on solid medium (Xu et al., 1998; Menand
et al., 2002; Mahfouz et al., 2006; Sormani et al., 2007; Leiber
et al., 2010; Ren et al., 2012), but all these groups did not
examine the functions of plant FKBP12s under anaerobic
growth condition. Only one group has shown that FKBP12
is functional in during anaerobic growth (Xiong and Sheen,
2012), but they did not set any solid medium control in their
experiments. In this study, we re-examined the functions of
AtFKBP12 along with HsFKBP12 and ScFKBP12 in Arabidopsis
under both anaerobic and aerobic growth conditions. Upon
submergence, overexpression of FKBP12s can significantly block
the growth of Arabidopsis in the presence of rapamycin. More
importantly, hypoxia caused by submergence can partially
rescue the functions of AtFKBP12 to interact with TOR and
rapamycin. Since Arabidopsis is land plant but not aquatic plant,
the biochemical and physiological processes of the submerged
seeds and seedlings should be quite different from seeds or
seedling growing under aerobic condition. Recent study also
revealed that submergence can lead to hypoxia and anaerobic
respiration in plant cells (Chen et al., 2015). It is possible
that the protein structure of AtFKBP12 can be altered to
contribute to the interaction between rapamycin, FKBP12 and
TOR under hypoxia stress. However, the underlying mechanism
is still remains to be defined. It should be noted that the
large amount of literatures already showed that rapamycin
treatment can generate the effects similar to hypoxic stress
and hypoxia inducible factor-1α (Hif1α), a key mediator of
cellular adaptation to hypoxia, can be efficiently inhibited by
rapamycin in mammals (Bedogni et al., 2005; Agarwal et al.,
2016; Damerill et al., 2016). Based on these observations, it is
not surprising that TOR signaling might also act as a key target
of hypoxia in Arabidopsis as observed in mammals (Hudson
et al., 2002; Arsham et al., 2003). Altogether, the combination of
rapamycin and hypoxia can generate additive inhibition effects
on plant growth in the presence of exogenous or endogenous
FKBP12s.
Our results also demonstrated that the rapamycin treatment,
ScFKBP12 transgenic lines showed the strongest drug sensitivity.
This might be explained in terms of amino acid sequences
(Figure 1E). Amino acid sequence alignment showed relatively
high similarity among ScFKBP12, HsFKBP12, and AtFKBP12.
The glycine residues and the drug-binding pocket are all
conserved (Clardy, 1995). However, two amino acids of
AtFKBP12, tyrosine at position 25 and isoleucine at position
79, were changed into cysteine (labeled with a red box in
Figure 1E), which affected the protein structure and its
biological activity (Xu et al., 1998). The existence of two
cysteines might also lead to the formation of a disulfide
bond, which would be a critical modification of protein
structure and corresponding enzymatic activity. Comparison
the amino acid sequence between ScFKBP12 andHsFKBP12,
twokey residuesGln54and Glu55in HsFKBP12interact to
rapamycin were changed into Gly60 and Gln61 in ScFKBP12
(Supplementary Figure 1B; Choi et al., 1996; Sormani et al.,
2007). Additionally, many different amino acids were also
observed in N-terminal of the proteins. These amino acid
differences likely lead to the different affinity rapamycin
binding between HsFKBP12 and ScFKBP12 in Arabidopsis,
but the detailed molecular mechanism remains to be further
defined.
The Combination of Rapamycin and KU
Significantly Inhibits Arabidopsis Growth
Rapamycin can inhibit TOR activity through rapamycin-
FKBP12-FRB/TOR complex formation and display a plateau
effect (Sormani et al., 2007; Ren et al., 2012). The second
generation TOR inhibitors (asTORis) inhibit TOR by targeting
the catalytic site of the kinase domain and competing with ATP
in a dose-dependent manner. KU is able to inhibit TORC1
and TORC2 with an IC50 of 10 nM in vitro but it inhibits
cell growth at 3µM in MEF cells (García-Martínez et al.,
2009) and the IC50 of rapamycin is 0.1nM in HEK293 cells
(Edwards and Wandless, 2007). The IC50 values of KU and
rapamycin in Arabidopsisare ∼5 and ∼1µM, respectively. This
suggests that the influx/eﬄux transporters and pharmacological
dynamics of TOR inhibitor drugs are quite different in animal
and plant cells. Rapamycin and KU precipitates occurred in MS
medium solution and plates when the drugs were used at high
concentrations (>5µM). The solubility of KU and rapamycin
is poor even in DMSO. This would act to reduce experimental
accuracy. An important strategy would be to combine these
two different kinds of TOR inhibitors with different inhibitory
mechanisms to suppress TOR function. The applications and
studies of Torin1, AZD8055, and KU in plants have shown
that KU is the most moderate inhibitor, but one with very
high TOR specificity. Therefore, we tried the combination of
rapamycin with KU to evaluate efficiency of TOR inhibition.
We found that TOR is strongly inhibited by a combination of
rapamycin and KU at low concentrations (1µM + 1µM). A
single inhibitor could not produce this level of inhibitory effect
at a 10-folds higher concentration. The inhibitor-combination
application effectively lowered the dosage of inhibitor and
reduced the experiment costs. Plant growth was completely
terminated once the concentration of rapamycin and KU was
5µM. However, the relationship between rapamycin and KU
during the actual process of inhibition remains elusive and
requires further investigation.
TOR Was Required for Plant Growth in
Respond to Auxin
Auxin plays an important role in the growth and development
of plants. Auxin activates TOR and promotes the translation
reinitiation of mRNA (Schepetilnikov et al., 2013). The TOR
inhibitor Torin1 can interfere with the auxin redistribution
(DR5-GFP) in root tips and root gravitropic responses indicating
a close connection between TOR and auxin (Dinkova et al., 2000;
Schepetilnikov et al., 2013). Some key genes associated with auxin
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signaling transduction are significantly mis-expressed when
TOR is suppressed by AZD8055 (Dong et al., 2015). Although
the approaches, TOR inhibitors (rapamycin/KU vs. Torin1)
and plant materials (AtFKBP12, HsFKBP12 and ScFKBP12
transgenic plants vs. TOR RNAi plants) we used are quite
different between ours and (Schepetilnikov et al., 2013), two
independent studies really reach to similar conclusion in which
TOR plays a crucial role in the auxin signaling transduction
(Schepetilnikov et al., 2013). However, Xiong et al. (2013)
demonstrated that auxin is decoupled from TOR signaling
activation, and thus auxin signaling (DR5-GFP) doesn’t alter
when TOR is suppressed (Xiong et al., 2013). These conflicting
observations likely caused by different experimental conditions.
Xiong et al. (2013), transiently treated the seedlings only for
few hours, whereas we and (Schepetilnikov et al., 2013), grow
seedlings for several days (Schepetilnikov et al., 2013; Xiong et al.,
2013). We observed that the strong growth and gravity defects
occurred in root when DR5/BP12-OE5 and DR5/BP12-OE11
was treated with rapamycin plus KU. The auxin distribution
significantly decreased in root tip when TOR was suppressed.
These results were highly consistent with the observation of
Schepetilnikov et al., but not with Xiong et al. (Schepetilnikov
et al., 2013; Xiong et al., 2013). Although Xiong et al., emphasized
that TOR was decoupled from auxin signaling in Arabidopsis,
many auxin signaling associated genes were also differentially
expressed in tor seedlings (Xiong et al., 2013). Importantly, some
overlapping differentially expressed genes were found in TOR
suppression plants by independent groups (Ren et al., 2012;
Xiong et al., 2013; Dong et al., 2015), indicating that TOR acts
as a key player in auxin signaling transduction in Arabidopsis.
However, the underlying molecular mechanism involving TOR
and auxin signals remains unclear. With establishment of the
DR5/BP12 system in this study, a highly potent, inducible, and
selective TOR suppression system is now available for advanced
studies on the relationship between TOR and auxin in plants.
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Supplementary Figure 1 | The protein expression level in three FKBP12
transgenic lines (A) and the multiple protein sequence alignment of
ScFKBP12, HsFKBP12, and AtFKBP12 (B). Key residues were marked with red
box.
Supplementary Figure 2 | Rapamycin sensitivity tests of the transgenic
plants with ScFKBP12, HsFKBP12, and AtFKBP12 inanaerobic growth
conditions (8 DAG). (A) The effect of rapamycin on the growth and development
of WT and three transgenic plants during anaerobic growth condition (8 DAG). Bar
= 0.5 cm. (B) The leaf growth of WT and three transgenic plants on 0.5MS liquid
medium supplied with DMSO or rapamycin (5µM). (B) Bar = 0.5 cm. (C)
Quantitative analysis and comparison of the fresh weight (%) of WT and three
transgenic plants after treatment with rapamycin. Error bars indicate ±SD for
quadruplication. Asterisks denote Student’s t-test significance compared with
control (∗P < 0.05;∗∗ P < 0.01).
Supplementary Figure 3 | Rapamycin cannot completely inhibit
DR5/BP12-OE lines growth even with very high concentration (20 µM)
(10DAG).
Supplementary Figure 4 | The inhibition of Arabidopsis by combined
rapamycin with KU. (A) The growth of whole plant of DR5:: GUS and
DR5/BP12-OE11 after treated with rapamycin and KU (10 DAG). Rapamycin
concentration ranged from 0 to 5µM, whereas KU was used in a final
concentration of 1µM. Bar = 1 cm. (B) The inhibition effect of rapamycin or KU or
rapamycin plus KU on root hair development and leaf formation of DR5::GUS and
DR5/BP12-OE11. Bar = 1mm at the left and 0.5 cm in the right. (C,D) The
quantitative analysis and comparison of root length and fresh weight (%) of
DR5::GUS and DR5/BP12-OE plants after treatment with rapamycin or/and KU.
(E) Detection expression level of auxin synthesis-related genes by qRT-PCR.
DR5/BP12-OE11 grew 12 days in 0.5MS medium with different TOR inhibitors
[RAP (1µM), KU (1µM), RAP (1µM) +KU (1µM); DMSO was used as control].
Each value represents the mean± SD of 3 independent experiments. Asterisks
denote Student’s t-test significance compared with control
(∗P < 0.05;∗∗ P < 0.01).
Supplementary Figure 5 | The expression level of auxin
biosynthesis-related genes and primaryauxin response genes were
affected by TOR specific inhibitors in short time treatment.
DR5/BP12-OE11grew in 0.5 MS medium for 10 days. Seedlings were transferred
into 0.5 MS medium containing TOR inhibitors [RAP (5µM), KU (5µM), RAP
(5µM)+KU (5µM); DMSO was used as control]for different time points (10min,
30min, 1 h, 2 h, 3 h, 6 h,12 h, 24 h), then root was collected for RNA extraction.
Each value represents the mean ± SD of 3 independent experiments.
Supplementary Table 1 | Primers were used in this study.
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